Developing first-in-class exercise-mimetic therapeutics that modulate metabolic, mitochondrial and contractile pathways to reproduce benefits of aerobic exercise. Aiming to treat obesity, heart failure, cognitive decline and muscle-wasting/frailty via preclinical LEAD-to-IND molecule programs to extend healthspan and longevity.